Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice
Min‐Wen Ku, Pierre Authié, Maryline Bourgine, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 12
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 210
Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate
Javier Villadiego, Juan García‐Arriaza, Reposo Ramírez‐Lorca, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 2, pp. 226-238
Open Access | Times Cited: 29
Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies
Dan Shan, Shaoyang Li, Ruichen Xu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 29
The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan
Xiang Liu, Helen Mostafavi, Wern Hann Ng, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 25
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
Benjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2984-2997
Open Access | Times Cited: 22
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
Kirill Nemirov, Maryline Bourgine, François Anna, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 846-846
Open Access | Times Cited: 13
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3
Use of lentiviral vectors in vaccination
Min‐Wen Ku, Pierre Charneau, Laleh Majlessi
Expert Review of Vaccines (2021) Vol. 20, Iss. 12, pp. 1571-1586
Open Access | Times Cited: 22
Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
Erica L. Stewart, Claudio Counoupas, Matt D. Johansen, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1405-1415
Open Access | Times Cited: 15
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4142-4142
Open Access | Times Cited: 14
Integrase deficient lentiviral vector: prospects for safe clinical applications
Chee-Hong Takahiro Yew, Narmatha Gurumoorthy, Fazlina Nordin, et al.
PeerJ (2022) Vol. 10, pp. e13704-e13704
Open Access | Times Cited: 14
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 8
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants
Hao Zhou, Ping Leng, Yang Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 15, pp. 2456-2470
Closed Access | Times Cited: 2
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity
Jodie Lopez, François Anna, Pierre Authié, et al.
Cell Reports (2022) Vol. 40, Iss. 4, pp. 111142-111142
Open Access | Times Cited: 11
Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine
Elizabeth Elder, Chandrashekar Bangalore Revanna, Catharina Johansson, et al.
Vaccine (2023) Vol. 41, Iss. 32, pp. 4743-4751
Open Access | Times Cited: 6
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Vaccinia Virus Strain Mva Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
Marı́a M. Lorenzo, Alejandro Marín-López, Kevin Chiem, et al.
(2023)
Open Access | Times Cited: 5
Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine
Laëtitia Douguet, Ingrid Fert, Jodie Lopez, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 5
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity
François Anna, Jodie Lopez, Fanny Moncoq, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1389-1404
Open Access | Times Cited: 5
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants
Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1364-1364
Open Access | Times Cited: 2
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease
Seok‐Chan Park, Laura Conti, Valentina Franceschi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
Platon Megagiannis, Guy A. Rouleau, Yang Zhou
Elsevier eBooks (2024), pp. 187-206
Closed Access
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
Kirill Nemirov, Pierre Authié, Philippe Souque, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion
Nishant Ranjan Chauhan, Soumya Kundu, Ramyasingh Bal, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113275-113275
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top